Healthcare / Health Information ServicesLSE
$0.63
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-190061.00 · quality 54.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-98.4%
↓Gross Margin
93.5%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+13.7%
FCF CAGR
—
FCF margin
-24.1%
FCF / Net income
0.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $788148.0 · net income $-400940.0 · FCF $-190061.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $788148.00 | $788148.00 | $750105.00 | $609390.00 | $535886.00 |
| Net Income | $-400940.00 | $-400940.00 | $-327103.00 | $-623816.00 | $-511601.00 |
| EBITDA | $-307456.00 | $-307456.00 | $-273039.00 | $-498550.00 | $-360284.00 |
| EPS | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Gross Margin | 93.5% | 93.5% | 99.0% | 98.1% | 99.7% |
| Operating Margin | -19.9% | -19.9% | -43.7% | -66.7% | -93.5% |
| Net Margin | -50.9% | -50.9% | -43.6% | -102.4% | -95.5% |
| Balance Sheet | |||||
| Current Ratio | 0.55 | 0.55 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-190061.00 | $-190061.00 | $-445141.00 | $-175234.00 | $-414601.00 |
| Returns | |||||
| ROE | -98.4% | -98.4% | -108.1% | -657.2% | -72.4% |
| Valuation | |||||
| P/B | 410.86 | 410.86 | 1107.41 | 9632.60 | 482.16 |
| Growth & Yield | |||||
| Revenue Growth | 5.1% | 5.1% | 23.1% | 13.7% | — |
| EPS Growth | -13.3% | -13.3% | 55.9% | -21.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-21.9%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.00 → -0.00
Residual
-21.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.